Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05275842 · ClinicalTrials.gov registry record · NA
CPT-L to Improve Outcomes for Individuals With HIV and PTSD
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05275842: Completed NA study, sponsored by Medical University of South Carolina.
NCT05275842 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05275842, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study plans to adapt and examine the acceptability and feasibility of an evidence-based PTSD treatment that has reduced other HIV transmission behavior (e.g., sexual risk), Cognitive Processing Therapy (CPT), at an HIV clinic as a strategy to improve HIV outcomes in this population.
Primary Outcome
The percentage of participants that were classified as eligible out of all participants that were screened for the purpose of the study.
Interventions
- BEHAVIORAL Cognitive Processing Therapy- Lifesteps (CPT-L)
- BEHAVIORAL Lifesteps
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2022-07-13 |
| Est. Completion | 2024-08-30 |
| Phase | NA |
What the finished NCT05275842 record still lists
NCT05275842 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive Processing Therapy- Lifesteps (CPT-L) is the first listed.
NCT05275842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05275842 about?
NCT05275842 is a clinical study titled "CPT-L to Improve Outcomes for Individuals With HIV and PTSD". This study plans to adapt and examine the acceptability and feasibility of an evidence-based PTSD treatment that has reduced other HIV transmission behavior (e.g., sexual risk), Cognitive Processing Therapy (CPT), at an HIV clinic as a strategy to improve HIV outcomes in this population.
What is the current status of trial NCT05275842?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2022-07-13. Estimated completion is 2024-08-30.
What interventions are being tested in trial NCT05275842?
The interventions under investigation include: Cognitive Processing Therapy- Lifesteps (CPT-L) (BEHAVIORAL), Lifesteps (BEHAVIORAL).
Who is sponsoring clinical trial NCT05275842?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05275842's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI